Combined PD-1, BRAF and MEK inhibition in BRAFV600E colorectal cancer: a phase 2 trial.
Nat Med
; 29(2): 458-466, 2023 02.
Article
in En
| MEDLINE
| ID: mdl-36702949
Full text:
1
Collection:
01-internacional
Health context:
6_ODS3_enfermedades_notrasmisibles
Database:
MEDLINE
Main subject:
Colorectal Neoplasms
/
Melanoma
Type of study:
Clinical_trials
Limits:
Humans
Language:
En
Journal:
Nat Med
Year:
2023
Document type:
Article